AMGAX
Price
$15.96
Change
+$0.09 (+0.57%)
Updated
Nov 13 closing price
RPTIX
Price
$112.99
Change
-$0.33 (-0.29%)
Updated
Nov 13 closing price
Ad is loading...

AMGAX vs RPTIX

Header iconAMGAX vs RPTIX Comparison
Open Charts AMGAX vs RPTIXBanner chart's image
Alger Mid Cap Growth A
Price$15.96
Change+$0.09 (+0.57%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$112.99
Change-$0.33 (-0.29%)
VolumeN/A
CapitalizationN/A
AMGAX vs RPTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMGAX vs. RPTIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGAX is a Buy and RPTIX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 32B vs. AMGAX (252M). RPTIX pays higher dividends than AMGAX: RPTIX (0.18) vs AMGAX (0.00). AMGAX was incepted earlier than RPTIX: AMGAX (28 years) vs RPTIX (9 years). AMGAX is a more actively managed with annual turnover of: 78.35 vs. RPTIX (21.70). AMGAX has a lower initial minimum investment than RPTIX: AMGAX (1000) vs RPTIX (500000). AMGAX annual gain was more profitable for investors over the last year : 34.72 vs. RPTIX (21.29). RPTIX return over 5 years is better than : 18.66 vs. AMGAX (7.25).
AMGAXRPTIXAMGAX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years9 years-
Gain YTD23.98413.037184%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets252M32B1%
Annual Yield % from dividends0.000.18-
Returns for 1 year34.7221.29163%
Returns for 3 years-36.75-14.64251%
Returns for 5 years7.2518.6639%
Returns for 10 years53.32N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNMD74.77-0.09
-0.12%
CONMED Corp
DOX92.71-0.15
-0.16%
Amdocs Limited
TERN7.17-0.29
-3.89%
Terns Pharmaceuticals
AUUD0.57-0.06
-8.93%
Auddia
EBS10.89-1.08
-9.02%
Emergent Biosolutions